Literature DB >> 6174984

Human prostate specific and shared differentiation antigens defined by monoclonal antibodies.

A E Frankel, R V Rouse, L A Herzenberg.   

Abstract

Splenic lymphocytes of BALB/c mice immunized with membrane-enriched fractions of human benign prostatic hyperplasia tissues were fused with the NS-1 light chain-secreting murine myeloma cell line. This generated hybridoma cultures that secreted immunoglobulins reactive in solid-phase radioimmunoassays with membrane preparations of prostatic tissues but not with membrane preparations of apparently normal human liver, spleen, thymus, or erythrocytes. After further screening of immunoglobulin reactivities and cloning of cultures, eight monoclonal antibodies were chosen that demonstrated reactivity with human prostate tissues. These monoclonal antibodies could be placed into at least three major groups--epithelium-specific, polyepithelial, and stroma-specific--on the basis of differential binding to the surfaces of various component cells in the prostate and other epithelia. Two antibodies defined unique protein antigens specific for prostate epithelia that were not crossreactive with prostatic acid phosphatase or the recently described "prostatic antigens." These antibodies also detected antigens on malignant prostate tissues as well as other malignant tissues. Four antibodies defined three unique polyepithelial protein antigens (two of the antibodies were different isotypes defining the same protein). Each of the polyepithelial antigens was expressed on a different spectrum of normal epithelial tissues. Two displayed brain tissue crossreactivity, one was present on pancreas, and one was present on platelets. The two antibodies that detected prostatic stromal protein antigens showed different spectra of reactivities. One antibody reacted with apparently all prostatic stromal cells as well as endothelial cells in the prostate and other organs. The other antibody apparently reacted with all prostatic stromal cells as well as myoepithelial and muscle cells in other organs.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6174984      PMCID: PMC345861          DOI: 10.1073/pnas.79.3.903

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  12 in total

1.  Indirect immunofluorescence for identification of prostatic epithelial cells.

Authors:  J E Pontes; B Choe; N Rose; J M Pierce
Journal:  J Urol       Date:  1977-04       Impact factor: 7.450

2.  Characterization of monoclonal antibodies to human melanoma-associated antigens.

Authors:  K Imai; A K Ng; S Ferrone
Journal:  J Natl Cancer Inst       Date:  1981-03       Impact factor: 13.506

3.  A rapid method for the detection of antibodies to cell surface antigens: a solid phase radioimmunoassay using cell membranes.

Authors:  F D Howard; J A Ledbetter; S Q Mehdi; L A Herzenberg
Journal:  J Immunol Methods       Date:  1980       Impact factor: 2.303

4.  In vivo effects of murine hybridoma monoclonal antibody in a patient with T-cell leukemia.

Authors:  R A Miller; D G Maloney; J McKillop; R Levy
Journal:  Blood       Date:  1981-07       Impact factor: 22.113

5.  Colorectal carcinoma-specific antigen: detection by means of monoclonal antibodies.

Authors:  M Herlyn; Z Steplewski; D Herlyn; H Koprowski
Journal:  Proc Natl Acad Sci U S A       Date:  1979-03       Impact factor: 11.205

6.  A human thymus-leukemia antigen defined by hybridoma monoclonal antibodies.

Authors:  R Levy; J Dilley; R I Fox; R Warnke
Journal:  Proc Natl Acad Sci U S A       Date:  1979-12       Impact factor: 11.205

7.  A unique cell surface antigen identifying lymphoid malignancies of B cell origin.

Authors:  L M Nadler; J Ritz; R Hardy; J M Pesando; S F Schlossman; P Stashenko
Journal:  J Clin Invest       Date:  1981-01       Impact factor: 14.808

8.  Purification of a human prostate specific antigen.

Authors:  M C Wang; L A Valenzuela; G P Murphy; T M Chu
Journal:  Invest Urol       Date:  1979-09

9.  A spectrum of monoclonal antibodies reactive with human mammary tumor cells.

Authors:  D Colcher; P H Hand; M Nuti; J Schlom
Journal:  Proc Natl Acad Sci U S A       Date:  1981-05       Impact factor: 11.205

10.  Human trophoblast cell-surface antigens defined by monoclonal antibodies.

Authors:  M Lipinski; D R Parks; R V Rouse; L A Herzenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1981-08       Impact factor: 11.205

View more
  5 in total

1.  Monoclonal antibody-defined antigens of human prostate cancer cell line PC3.

Authors:  J Lindgren; M Blaszczyk; B Atkinson; Z Steplewski; H Koprowski
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

2.  Monoclonal antibodies to different epitopes on a prostate tumor-associated antigen. Implications for immunotherapy.

Authors:  K S Webb; J L Ware; S F Parks; W H Briner; D F Paulson
Journal:  Cancer Immunol Immunother       Date:  1983       Impact factor: 6.968

3.  Characterization of prostate-tissue-directed monoclonal antibody, alpha-Pro 13.

Authors:  K S Webb; D F Paulson; S F Parks; F L Tuck; P J Walther; J L Ware
Journal:  Cancer Immunol Immunother       Date:  1984       Impact factor: 6.968

4.  Engineered cell surface expression of membrane immunoglobulin as a means to identify monoclonal antibody-secreting hybridomas.

Authors:  Paul W Price; Elizabeth C McKinney; Youliang Wang; Loren E Sasser; Muthugapatti K Kandasamy; Linda Matsuuchi; Christine Milcarek; Roger B Deal; Deborah G Culver; Richard B Meagher
Journal:  J Immunol Methods       Date:  2009-01-31       Impact factor: 2.303

5.  A novel hybridoma antibody (PASE/4LJ) to human prostatic acid phosphatase suitable for immunohistochemistry.

Authors:  A M Haines; S E Larkin; A P Richardson; R W Stirling; E Heyderman
Journal:  Br J Cancer       Date:  1989-12       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.